{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:07:10Z","timestamp":1789326430958,"version":"build-2803163510"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Osteoarthritis (OA) is becoming a major medical burden worldwide due\nto changing lifestyles and aging populations. Osteoarthritis is a disease characterized by a variety\nof anatomic and physiological changes to joints, including cartilage degradation, bone remodeling,\nand the formation of osteophytes. These changes cause pain, stiffness, swelling, and limitations\nin joint function. Glucosamine serves as a fundamental constituent for cartilage, the resilient\nconnective tissue responsible for cushioning joints. Glucosamine Sulphate Potassium Chloride\n(GSPC) supplementation is widely employed to mitigate symptoms linked to osteoarthritis, a degenerative\njoint disorder hallmarked by cartilage degradation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>Palliative care aims at minimizing pain and disability and improving function, performance,\nand quality of life. In this study, the emulgel formulation of GSPC was developed and checked for\nits potential.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Currently, OA does not have a definitive treatment. Since conventional dosage forms\ncannot deliver the active drug content at a predefined target site in a predictable manner throughout\nthe treatment period, a new carrier system is always required. Considering their reduced size,\ntargeting potential, and site specificity, nanocarrier-based approaches could hold an answer to\nshortcomings associated with conventional routes. Thus, the objective of the current study was to\nformulate and characterize glucosamine sulphate potassium chloride-loaded emulgel for the treatment\nof osteoarthritis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Microemulsion of glucosamine sulphate potassium chloride was formulated using a\nspontaneous emulsification method comprising of oleic acid (oil phase), Tween 80, Tween 20 (surfactant)\nand PEG 400, Span 80 (co-surfactant), and distilled water (aqueous phase). The microemulsions\nwere evaluated for surface morphology, globule size, poly-dispersibility index (PDI), zeta\npotential, and viscosity, and the final batch of microemulsions was selected.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>The optimized microemulsion contained 35% co-surfactant (propylene glycol), 20% surfactant\n(Tween 20), and 15% oil (oleic acid) and glucosamine sulphate potassium chloride in a\ndose of 60 mg, which has sufficient drug loading capacity with a droplet size of 182 nm for optimized\nformulation. The optimized microemulsion formulation was added to gel prepared by Carbopol\n934 in a 1:1 (w\/w) ratio, leading to the formulation of glucosamine sulphate potassium chloride-\ncontaining emulgel. The prepared emulgel was further evaluated for viscosity, drug content,\npH, and in vitro drug release. Emulgel formulation (F6) showed 88% drug release after 6 hours,\nand it followed the Higuchi model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Glucosamine Sulphate Potassium Chloride (GSPC) is used in the treatment of OA by\nincreasing the production of proteoglycans, which can cause the cartilage to break down. Emulgel\nformulation (F3) showed 75.41% drug release, and formulation (F6) showed 88% drug release after\n6 h. Therefore, it may be concluded that an emulgel of GSPC can be used as a controlled-release\ndosage form of the drug for local application in OA.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115733971291114240326042453","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T08:54:00Z","timestamp":1712307240000},"page":"97-108","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Formulation and Characterization of Glucosamine Sulphate Potassium Chloride (GSPC) Loaded Emulgel for the Treatment of Osteoarthritis"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-7465","authenticated-orcid":true,"given":"Komal","family":"Rao","sequence":"first","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram, Haryana 122103,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Kumari","sequence":"additional","affiliation":[{"name":"M.E.T Faculty of Pharmacy, Moradabad, Uttar Pradesh 244001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4972","authenticated-orcid":true,"given":"Neha","family":"Minocha","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University,\nGurugram, Haryana 122413, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bioactmat.2021.06.035","volume":"8","author":"Mei H.","year":"2022","unstructured":"Mei H.; Cai S.; Huang D.; Gao H.; Cao J.; He B.; Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification. Bioact Mater  2022,8,220-240","journal-title":"Bioact Mater"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.26452\/ijrps.v11i1.1831","volume":"11","author":"Sharadha M","year":"2020","unstructured":"Sharadha M ; Gowda D.V.; Vishal Gupta N.; Akhila A.R.; An overview on topical drug delivery system \u2013 Updated review. Int J Pharm Sci Res  2020,11(1),368-385","journal-title":"Int J Pharm Sci Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5530\/jyp.2021.13.17","volume":"13","author":"Charyulu N.R.","year":"2021","unstructured":"Charyulu N.R.; Joshi P.; Dubey A.; Shetty A.; Emulgel: A boon for enhanced topical drug delivery. J Young Pharm  2021,13(1),76-79","journal-title":"J Young Pharm"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.26452\/ijrps.v9i1.1176","volume":"9","author":"Pandey P.","year":"2018","unstructured":"Pandey P.; Ramkishan A.; Dureja H.; Optimizing the formulation variables for erlotinib loaded chitosan nanoparticles. Int J Pharm Sci Res  2018,9(12),5234-5239","journal-title":"Int J Pharm Sci Res"},{"key":"ref=5","first-page":"43","volume":"09","author":"Kushwaha N.","year":"2020","unstructured":"Kushwaha N.; Use of nanotechnology in cosmeceuticals: A review. Int J Pharm Sci Invent  2020,09(01),43-51","journal-title":"Int J Pharm Sci Invent"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.matpr.2022.09.494","volume":"69","author":"Minocha N.","year":"2022","unstructured":"Minocha N.; Kumar V.; Nanostructure system: Liposome \u2013 A bioactive carrier in drug delivery systems. Mater Today Proc  2022,69,614-619","journal-title":"Mater Today Proc"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.matpr.2022.08.306","volume":"69","author":"Kumar V.","year":"2022","unstructured":"Kumar V.; Minocha N.; Garg V.; Dureja H.; Nanostructured materials used in drug delivery. Mater Today Proc  2022,69,174-180","journal-title":"Mater Today Proc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/1872210516666220523120313","volume":"17","author":"Pandey P.","year":"2023","unstructured":"Pandey P.; Purohit D.; Sharma S.; Lamba A.K.; Saini S.; Minocha N.; Vashist N.; Kaushik D.; Nanocrystals: A deep insight into formulation aspects, stabilization strategies, and biomedical applications. Recent Pat Nanotechnol  2023,17(4),307-326","journal-title":"Recent Pat Nanotechnol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/1872210516666220317143351","volume":"17","author":"Minocha N.","year":"2023","unstructured":"Minocha N.; Sharma N.; Verma R.; Kaushik D.; Pandey P.; Solid lipid nanoparticles: Peculiar strategy to deliver bio-proactive molecules. Recent Pat Nanotechnol  2023,17(3),228-242","journal-title":"Recent Pat Nanotechnol"},{"key":"ref=10","volume":"1","author":"Bhowmik D.","year":"2012","unstructured":"Bhowmik D.; Recent advances in novel topical drug delivery system. Pharma Innov  2012,1(9)","journal-title":"Pharma Innov"},{"key":"ref=11","first-page":"14","volume":"1","author":"Imran K.T.","year":"2011","unstructured":"Imran K.T.; Gore S.; Giradkar P.; A review advances in topical drug delivery system. Int J Pharm Res Allied Sci  2011,1,14-23","journal-title":"Int J Pharm Res Allied Sci"},{"key":"ref=12","first-page":"51","volume":"2","author":"Jani R.","year":"2010","unstructured":"Jani R.; Jani K.; Mallikarjuna S.C.; Patel D.; Preparation and evaluation of topical gel valdecoxib. Int J Pharm Sci Res  2010,2(1),51-54","journal-title":"Int J Pharm Sci Res"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v8i2.44527","volume":"8","author":"Pathan I.B.","year":"2009","unstructured":"Pathan I.B.; Setty C.M.; Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res  2009,8(2)","journal-title":"Trop J Pharm Res"},{"key":"ref=14","first-page":"273","volume":"9","author":"Thomas J.","year":"2017","unstructured":"Thomas J.; Kuppuswamy S.; Sahib A.; Benedict A.; George E.; A review on emulgel as a current trend in topical drug delivery systems. Int J Pharmacol Res  2017,9(3),273-281","journal-title":"Int J Pharmacol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.cclet.2018.10.037","volume":"29","author":"Zhou X.","year":"2018","unstructured":"Zhou X.; Hao Y.; Yuan L.; Pradhan S.; Shrestha K.; Pradhan O.; Liu H.; Li W.; Nano-formulations for transdermal drug delivery: A review. Chin Chem Lett  2018,29(12),1713-1724","journal-title":"Chin Chem Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.wndm.2020.100179","volume":"28","author":"Abdo J.M.","year":"2020","unstructured":"Abdo J.M.; Sopko N.A.; Milner S.M.; The applied anatomy of human skin: A model for regeneration. Wound Medicine  2020,28,100179","journal-title":"Wound Medicine"},{"key":"ref=17","first-page":"9","volume":"5","author":"Magbool F.F.","year":"2018","unstructured":"Magbool F.F.; Elnima E.I.; Shayoub M.E.; Hamedelniel E.I.; Design, formulation, and evaluation of Carbopol 940 and xanthan gum as gel bases for oral local drug delivery for oral mucosal infectious diseases. Eur J Biomed PharmSci  2018,5(10),9-21","journal-title":"Eur J Biomed PharmSci"},{"key":"ref=18","first-page":"4733","volume":"7","author":"Kumar D.","year":"2016","unstructured":"Kumar D.; Singh J.; Antil M.; Kumar V.; Emulgel-novel topical drug delivery system\u2013a comprehensive review. Int J Pharm Sci Res  2016,7(12),4733-4742","journal-title":"Int J Pharm Sci Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/2210303112666220818115231","volume":"12","author":"Kaushik D.","year":"2022","unstructured":"Kaushik D.; Pandey P.; Minocha N.; Vashist N.; Shah R.; Saini S.; Makhija M.; Purohit D.; Emulgel: An emerging approach towards effective topical drug delivery. Drug Deliv Lett  2022,12(4),227-242","journal-title":"Drug Deliv Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2174\/1573401318666220601150053","volume":"19","author":"Rao K.","year":"2023","unstructured":"Rao K.; Minocha N.; Glucosamine sulphate potassium chloride in the management of osteoarthritis- considering emulgel dosage form: A review. Curr Nutr Food Sci  2023,19(4),419-427","journal-title":"Curr Nutr Food Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/03639045.2020.1717515","volume":"46","author":"Torregrosa A.","year":"2020","unstructured":"Torregrosa A.; Ochoa-Andrade A.T.; Parente M.E.; Vidarte A.; Guarinoni G.; Savio E.; Development of an emulgel for the treatment of rosacea using quality by design approach. Drug Dev Ind Pharm  2020,46(2),296-308","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=22","first-page":"30","volume":"1","author":"Jain S.K.","year":"2019","unstructured":"Jain S.K.; Bajapi P.; Modi S.K.; Gupta P.; A review on emulgel, as a novel trend in topical drug delivery system. Recent Trends PharmSci Res  2019,1(2),30-39","journal-title":"Recent Trends PharmSci Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"Hunter D.J.","year":"2019","unstructured":"Hunter D.J.; Bierma-Zeinstra S.; Osteoarthritis. Lancet  2019,393(10182),1745-1759","journal-title":"Lancet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00296-012-2416-2","volume":"32","author":"Reginster J.Y.","year":"2012","unstructured":"Reginster J.Y.; Neuprez A.; Lecart M.P.; Sarlet N.; Bruyere O.; Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int  2012,32(10),2959-2967","journal-title":"Rheumatol Int"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/md19100542","volume":"19","author":"Eckert T.","year":"2021","unstructured":"Eckert T.; J\u00e4hrling-Butkus M.; Louton H.; Burg-Roderfeld M.; Zhang R.; Zhang N.; Hesse K.; Petridis A.K.; Ko\u017e\u00e1r T.; Steinmeyer J.; Schauer R.; Engelhard P.; Kozarova A.; Hudson J.W.; Siebert H.C.; Efficacy of chondroprotective food supplements based on collagen hydrolysate and compounds isolated from marine organisms. Mar Drugs  2021,19(10),542","journal-title":"Mar Drugs"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cosmetics10010036","volume":"10","author":"Pikosz K.","year":"2023","unstructured":"Pikosz K.; Nowak I.; Feliczak-Guzik A.; Potential of icariin\u2013glucosamine combination in the treatment of osteoarthritis by topical application: Development of topical formulation and in vitro permeation study. Cosmetics  2023,10(1),36","journal-title":"Cosmetics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/969012","volume":"2011","author":"Jerosch J.","year":"2011","unstructured":"Jerosch J.; Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially omega-3 fatty acids. Int J Rheumatol  2011,2011,1-17","journal-title":"Int J Rheumatol"},{"key":"ref=28","first-page":"523","volume":"30","author":"Cohen M.","year":"2003","unstructured":"Cohen M.; Wolfe R.; Mai T.; Lewis D.; A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol  2003,30(3),523-528","journal-title":"J Rheumatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1021\/acsomega.9b03702","volume":"5","author":"Zhang N.","year":"2020","unstructured":"Zhang N.; Liu C.; Jin L.; Zhang R.; Siebert H.C.; Wang Z.; Prakash S.; Yin X.; Li J.; Hou D.; Sun B.; Liu M.; Influence of long-chain\/medium-chain triglycerides and whey protein\/Tween 80 ratio on the stability of phosphatidylserine emulsions (O\/W). ACS Omega  2020,5(14),7792-7801","journal-title":"ACS Omega"},{"key":"ref=30","first-page":"238","volume":"8","author":"Kasiramar G.K.","year":"2015","unstructured":"Kasiramar G.K.; Komala S.; Soundarya R.; Parthiban S.; Bharathi B.; Elango S.; Review on emulgel formulations with nonsteroidal anti-inflammatory drugs for topical administration. Pharma Sci Monitor  2015,8(1),238-254","journal-title":"Pharma Sci Monitor"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5530\/srp.2017.1.8","volume":"8","author":"Kale S.N.","year":"2016","unstructured":"Kale S.N.; Deore S.L.; Emulsion, microemulsion, and nanoemulsion: A review. Syst Rev Pharm  2016,8(1),39-47","journal-title":"Syst Rev Pharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1574891X14666190717111531","volume":"14","author":"Anand K.","year":"2019","unstructured":"Anand K.; Ray S.; Rahman M.; Shaharyar A.; Bhowmik R.; Bera R.; Karmakar S.; Nano-emulgel: Emerging as a smarter topical lipidic emulsion-based nanocarrier for skin healthcare applications. Recent Patents Anti-Infect Drug Disc  2019,14(1),16-35","journal-title":"Recent Patents Anti-Infect Drug Disc"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2471-9935.100010","volume":"2","author":"latha Samala M.","year":"2016","unstructured":"latha Samala M.; Sridevi G.; Role of polymers as gelling agents in the formulation of Emulgels. Polymer science  2016,2(1),1-8","journal-title":"Polymer science"},{"key":"ref=34","first-page":"529","volume":"9","author":"Banyal M.","year":"2020","unstructured":"Banyal M.; Joshi S.; Emulgel: An enormous approach for topical delivery of hydrophobic drugs. World J Pharm Res  2020,9(13),529-550","journal-title":"World J Pharm Res"},{"key":"ref=35","first-page":"1179","volume":"8","author":"Raju K.","year":"2019","unstructured":"Raju K.; Sneha G.; Khatoon R.; Ashwini M.; Shirisha G.; Ajay B.; Bongoni R.N.; Formulation and evaluation of ornidazole topical emulgel. World J Pharm Pharm Sci  2019,8,1179-1197","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=36","first-page":"85","volume":"3","author":"Shankar D.","year":"2018","unstructured":"Shankar D.; Dhobale S.; Shelke G.; Gajanan J.; Suresh J.; Gaikwad D.; Formulation and evaluation of luliconazole emulgel for topical drug delivery. Int Res J Sci Eng  2018,3,85-89","journal-title":"Int Res J Sci Eng"},{"key":"ref=37","volume":"12","author":"Tanaji D.N.","year":"2018","unstructured":"Tanaji D.N.; Emulgel: A comprehensive review for topical delivery of hydrophobic drugs. Asian J Pharm  2018,12(02)","journal-title":"Asian J Pharm"},{"key":"ref=38","first-page":"712","volume":"11","author":"Pakhare A.V.","year":"2017","unstructured":"Pakhare A.V.; Deshmane S.V.; Deshmane S.S.; Biyani K.R.; Design and development of emulgel preparation containing diclofenac potassium. Asian J Pharm  2017,11(04),712-716","journal-title":"Asian J Pharm"},{"key":"ref=39","first-page":"77","volume":"3","author":"Chime S.A.","year":"2014","unstructured":"Chime S.A.; Kenechukwu F.C.; Attama A.A.; Nanoemulsions\u2014advances in formulation, characterization and applications in drug delivery. In: Application of Nanotechnology in Drug Delivery  2014,3,77-126","journal-title":"In: Application of Nanotechnology in Drug Delivery"},{"key":"ref=40","author":"Schleck J.R.","year":"1998","unstructured":"Schleck J.R.; Burger C.M.; Chopdekar V.M.; Glucosamine sulfate potassium chloride and process of preparation thereof.  1998"},{"key":"ref=41","unstructured":"PubChem Compound Summary for CID 76965765, Glucosamine Sulfate Potassium Chloride.   Available from:  https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Glucosamine-Sulfate-Potassium-Chloride"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971291114240326042453","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228608\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971291114240326042453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:50:51Z","timestamp":1738234251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228608\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733971291114240326042453","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}